EFFECTS OF SELECTIVE ET(B)-RECEPTOR STIMULATION ON ARTERIAL, VENOUS AND CAPILLARY FUNCTIONS IN CAT SKELETAL-MUSCLE

被引:25
作者
EKELUND, U
ADNER, M
EDVINSSON, L
MELLANDER, S
机构
[1] LUND UNIV,DEPT MED,LUND,SWEDEN
[2] UNIV LUND HOSP,S-22185 LUND,SWEDEN
关键词
ARTERIES; CAPILLARIES; CAPILLARY PRESSURE; ENDOTHELINS; ET(A)-RECEPTOR; ET(B)-RECEPTOR; MICROCIRCULATION; PROSTACYCLIN; VEINS;
D O I
10.1111/j.1476-5381.1994.tb13163.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 This paper describes, in quantitative terms, the in vivo effects of two selective ET(B)-receptor agonists (IRL 1620 and BQ 3020) on vascular resistance (tone) in the following consecutive sections of the vascular bed of sympathectomized cat skeletal muscle: large-bore arterial resistance vessels (>25 mu m), small arterioles (<25 mu m) and the veins. The effects on capillary pressure and transcapillary fluid exchange were also recorded. 2 Both IRL 1620 and BQ 3020, infused i.a. to the muscle preparation, evoked an initial transient dilator response followed by a moderate dose-dependent constrictor response, both being preferentially confined to the small arterioles. The dilator response was associated with a transient increase, and the constrictor response with a sustained decrease, in capillary pressure, the latter causing net transcapillary fluid absorption. The capillary filtration coefficient decreased during the constrictor response, indicating constriction of terminal arterioles/precapillary sphincters. 3 The vascular responses to the ET(B)-receptor agonists were unaffected by blockade of endothelium-derived nitric oxide (N-G-nitro-L-arginine methyl ester) and by selective ET(A)-receptor blockade (FR139317). However, blockade of prostacyclin production with indomethacin decreased the amplitude of the dilator response, and decreased the time required to reach a steady-state vasoconstrictor response to the ET(B)-receptor agonists. 4 The effect of ET(B)-receptor stimulation on vascular tone was also evaluated in vitro on the cat femoral artery and vein. IRL 1620 had no effect on the femoral artery but caused a weak dose-dependent relaxation in the femoral vein. This large vein relaxation response seemed to be mediated by endothelium-derived nitric oxide and not by prostacyclin. 5 It may be concluded that ET(B)-receptor stimulation is responsible for the dilator response, and can contribute to the constrictor response, elicited by endothelins in cat skeletal muscle in vivo.
引用
收藏
页码:887 / 894
页数:8
相关论文
共 28 条
[1]  
ARAMORI I, 1992, J BIOL CHEM, V267, P12468
[2]   DISCRIMINATION BETWEEN ETA-RECEPTOR-MEDIATED AND ETB-RECEPTOR-MEDIATED EFFECTS OF ENDOTHELIN-1 AND [ALA1,3,11,15]ENDOTHELIN-1 BY BQ-123 IN THE ANESTHETIZED RAT [J].
BIGAUD, M ;
PELTON, JT .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (04) :912-918
[3]   SITE OF AUTOREGULATORY REACTIONS IN THE VASCULAR BED OF CAT SKELETAL-MUSCLE AS DETERMINED WITH A NEW TECHNIQUE FOR SEGMENTAL VASCULAR-RESISTANCE RECORDINGS [J].
BJORNBERG, J ;
GRANDE, PO ;
MASPERS, M ;
MELLANDER, S .
ACTA PHYSIOLOGICA SCANDINAVICA, 1988, 133 (02) :199-210
[4]   HUMAN BIG-ENDOTHELIN-1 AND ENDOTHELIN-1 RELEASE PROSTACYCLIN VIA THE ACTIVATION OF ET1 RECEPTORS IN THE RAT PERFUSED LUNG [J].
DORLEANSJUSTE, P ;
TELEMAQUE, S ;
CLAING, A ;
IHARA, M ;
YANO, M .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (04) :773-775
[5]   IN-VIVO EFFECTS OF ENDOTHELIN-1 AND ET(A) RECEPTOR BLOCKADE ON ARTERIAL, VENOUS AND CAPILLARY FUNCTIONS IN SKELETAL-MUSCLE [J].
EKELUND, U ;
ALBERT, U ;
EDVINSSON, L ;
MELLANDER, S .
ACTA PHYSIOLOGICA SCANDINAVICA, 1993, 148 (03) :273-283
[6]   MYOGENIC VASCULAR REGULATION IN SKELETAL-MUSCLE INVIVO IS NOT DEPENDENT OF ENDOTHELIUM-DERIVED NITRIC-OXIDE [J].
EKELUND, U ;
BJORNBERG, J ;
GRANDE, PO ;
ALBERT, U ;
MELLANDER, S .
ACTA PHYSIOLOGICA SCANDINAVICA, 1992, 144 (02) :199-207
[7]  
EKELUND U, 1994, ACTA PHYSL SCAND, V140, P47
[8]  
FOLKOW B, 1970, CAPILLARY PERMEABILI, P614
[9]   NG-MONOMETHYL-L-ARGININE DOES NOT INHIBIT THE HINDQUARTERS VASODILATOR ACTION OF ENDOTHELIN-1 IN CONSCIOUS RATS [J].
GARDINER, SM ;
COMPTON, AM ;
BENNETT, T ;
PALMER, RMJ ;
MONCADA, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 171 (2-3) :237-240
[10]  
GARDINER SM, 1994, IN PRESS BR J PHARM